Skip to main content
Top
Published in: Diabetologia 10/2015

01-10-2015 | Article

Risk factors for atrial fibrillation in type 2 diabetes: report from the Swedish National Diabetes Register (NDR)

Authors: Björn Zethelius, Soffia Gudbjörnsdottir, Björn Eliasson, Katarina Eeg-Olofsson, Ann-Marie Svensson, Jan Cederholm

Published in: Diabetologia | Issue 10/2015

Login to get access

Abstract

Aims/hypothesis

Atrial fibrillation (AF) is more frequent in patients with diabetes than in the general population. However, characteristics contributing to AF risk in diabetes remain speculative.

Methods

Observational study of 83,162 patients with type 2 diabetes, aged 30-79 years, with no baseline AF, 17% had history of cardiovascular disease (CVD) and 3.3% history of congestive heart failure (CHF), followed up for development of AF during mean 6.8 years from 2005–2007 to 2012. A subgroup of 67,780 patients without history of CVD or CHF was also analysed.

Results

Using Cox regression, cardiovascular risk factors associated with risk for AF were updated mean BMI (HR 1.31 per 5 kg/m2) or obesity (HR 1.51), updated mean systolic BP (SBP; HR 1.13 per 10 mmHg) or hypertension (HR 1.71), and cumulative microalbuminuria (HR 1.21), p < 0.001 for all analyses. Male sex, increasing age and height were also significant predictors. HRs were 1.76 for a history of CHF and 2.56 for in-study CHF, while 1.32 for history of CVD and 1.38 for in-study CHD (p < 0.001). Among patients without history of CVD or CHF, significant predictors were similarly BMI, SBP, and cumulative microalbuminuria and CHF. The risk of AF differed in the subgroups achieving or not achieving a target BP < 140/85 mmHg. The HRs for AF were (per 10 mmHg increase) 0.88 and 1.24, respectively.

Conclusions/interpretation

The modifiable risk factors high BP, high BMI and albuminuria were strongly associated with AF in type 2 diabetes. CVD, advancing age and height were also associated with AF in type 2 diabetes.
Appendix
Available only for authorised users
Literature
1.
go back to reference Go AS, Hylek EM, Phillips KA et al (2001) Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 285:2370–2375CrossRefPubMed Go AS, Hylek EM, Phillips KA et al (2001) Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 285:2370–2375CrossRefPubMed
2.
go back to reference Kannel WB, Abbott RD, Savage DD, McNamara PM (1982) Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med 306:1018–1022CrossRefPubMed Kannel WB, Abbott RD, Savage DD, McNamara PM (1982) Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med 306:1018–1022CrossRefPubMed
3.
go back to reference Friberg J, Scharling H, Gadsbøll N, Truelsen T, Jensen GB, Copenhagen City Heart Study (2004) Comparison of the impact of atrial fibrillation on the risk of stroke and cardiovascular death in women versus men (The Copenhagen City Heart Study). Am J Cardiol 94:889–894CrossRefPubMed Friberg J, Scharling H, Gadsbøll N, Truelsen T, Jensen GB, Copenhagen City Heart Study (2004) Comparison of the impact of atrial fibrillation on the risk of stroke and cardiovascular death in women versus men (The Copenhagen City Heart Study). Am J Cardiol 94:889–894CrossRefPubMed
4.
go back to reference Benjamin EJ, Levy D, Vaziri SM, D’Agostino RB, Belanger AJ, Wolf PA (1994) Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 271:840–844CrossRefPubMed Benjamin EJ, Levy D, Vaziri SM, D’Agostino RB, Belanger AJ, Wolf PA (1994) Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 271:840–844CrossRefPubMed
5.
go back to reference Schnabel RB, Pencina MJ, D’Agostino RB Sr et al (2009) Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study. Lancet 373:739–745PubMedCentralCrossRefPubMed Schnabel RB, Pencina MJ, D’Agostino RB Sr et al (2009) Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study. Lancet 373:739–745PubMedCentralCrossRefPubMed
6.
go back to reference Östgren CJ, Merlo J, Råstam L, Lindblad U (2004) For Skaraborg Hypertension and Diabetes Project. Atrial fibrillation and its association with type 2 diabetes and hypertension in a Swedish community. Diab Obes Metab 6:367–374CrossRef Östgren CJ, Merlo J, Råstam L, Lindblad U (2004) For Skaraborg Hypertension and Diabetes Project. Atrial fibrillation and its association with type 2 diabetes and hypertension in a Swedish community. Diab Obes Metab 6:367–374CrossRef
7.
go back to reference Smith JG, Platonov PG, Hedblad B, Engström G, Melander O (2010) Atrial fibrillation in the Malmö diet and cancer study: a study of occurrence, risk factors and diagnostic validity. Eur J Epidemiol 25:95–102CrossRefPubMed Smith JG, Platonov PG, Hedblad B, Engström G, Melander O (2010) Atrial fibrillation in the Malmö diet and cancer study: a study of occurrence, risk factors and diagnostic validity. Eur J Epidemiol 25:95–102CrossRefPubMed
8.
go back to reference Rosengren A, Hauptman PJ, Lappas G, Olsson L, Wilhelmsen L, Swedberg K (2009) Big men and atrial fibrillation: effects of body size and weight gain on risk of atrial fibrillation in men. Eur Heart J 30:1113–1120CrossRefPubMed Rosengren A, Hauptman PJ, Lappas G, Olsson L, Wilhelmsen L, Swedberg K (2009) Big men and atrial fibrillation: effects of body size and weight gain on risk of atrial fibrillation in men. Eur Heart J 30:1113–1120CrossRefPubMed
9.
go back to reference Huxley RR, Lopez FL, Folsom AR et al (2011) Absolute and attributable risks of atrial fibrillation in relation to optimal and borderline risk factors: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 123:1501–1508PubMedCentralCrossRefPubMed Huxley RR, Lopez FL, Folsom AR et al (2011) Absolute and attributable risks of atrial fibrillation in relation to optimal and borderline risk factors: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 123:1501–1508PubMedCentralCrossRefPubMed
10.
go back to reference Huxley RR, Filion KB, Konety S, Alonso A (2011) Meta-analysis of cohort and case–control studies of type 2 diabetes mellitus and risk of atrial fibrillation. Am J Cardiol 108:56–62PubMedCentralCrossRefPubMed Huxley RR, Filion KB, Konety S, Alonso A (2011) Meta-analysis of cohort and case–control studies of type 2 diabetes mellitus and risk of atrial fibrillation. Am J Cardiol 108:56–62PubMedCentralCrossRefPubMed
11.
12.
go back to reference Du X, Ninomiya T, de Galan B, on behalf of the ADVANCE Collaborative Group et al (2009) Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study. Eur Heart J 30:1128–1135CrossRefPubMed Du X, Ninomiya T, de Galan B, on behalf of the ADVANCE Collaborative Group et al (2009) Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study. Eur Heart J 30:1128–1135CrossRefPubMed
13.
go back to reference Zethelius B, Eliasson B, Cederholm J et al (2011) A new model for 5-year risk of cardiovascular disease in type 2 diabetes – from the Swedish National Diabetes Register (NDR). Diab Res Clin Pract 93:276–284CrossRef Zethelius B, Eliasson B, Cederholm J et al (2011) A new model for 5-year risk of cardiovascular disease in type 2 diabetes – from the Swedish National Diabetes Register (NDR). Diab Res Clin Pract 93:276–284CrossRef
14.
go back to reference Asia Pacific Cohort Studies Collaboration (2003) The effects of diabetes on the risks of major cardiovascular diseases and death in the Asia-Pacific region. The Asia Pacific Cohort Studies Collaboration. Diabetes Care 26:360–366CrossRef Asia Pacific Cohort Studies Collaboration (2003) The effects of diabetes on the risks of major cardiovascular diseases and death in the Asia-Pacific region. The Asia Pacific Cohort Studies Collaboration. Diabetes Care 26:360–366CrossRef
15.
go back to reference Huxley R, Barzi F, Woodward M (2006) Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ 332:73–78PubMedCentralCrossRefPubMed Huxley R, Barzi F, Woodward M (2006) Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ 332:73–78PubMedCentralCrossRefPubMed
17.
go back to reference Eeg-Olofsson K, Cederholm J, Nilsson PM et al (2010) New aspects of HbA1c as a risk factor for cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register (NDR). J Intern Med 268:471–482CrossRefPubMed Eeg-Olofsson K, Cederholm J, Nilsson PM et al (2010) New aspects of HbA1c as a risk factor for cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register (NDR). J Intern Med 268:471–482CrossRefPubMed
18.
go back to reference Cederholm J, Zethelius B, Gudbjörnsdottir S et al (2009) Effect of tight control of HbA1c and blood pressure on cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register (NDR). Diab Res Clin Pract 86:74–81CrossRef Cederholm J, Zethelius B, Gudbjörnsdottir S et al (2009) Effect of tight control of HbA1c and blood pressure on cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register (NDR). Diab Res Clin Pract 86:74–81CrossRef
19.
go back to reference Gudbjörnsdottir S, Eliasson B, Cederholm J, on behalf of the National Diabetes Register (NDR) et al (2011) Additive effects of glycaemia and dyslipidaemia on risk of cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register. Diabetologia 54:2544–2551CrossRefPubMed Gudbjörnsdottir S, Eliasson B, Cederholm J, on behalf of the National Diabetes Register (NDR) et al (2011) Additive effects of glycaemia and dyslipidaemia on risk of cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register. Diabetologia 54:2544–2551CrossRefPubMed
20.
go back to reference Cederholm J, Gudbjörnsdottir S, Eliasson B, Zethelius B, Eeg-Olofsson K, Nilsson P (2012) Blood pressure and risk of cardiovascular diseases in type 2 diabetes: further findings from the Swedish National Diabetes Register (NDR-BP II). J Hypertens 30:2020–2030CrossRefPubMed Cederholm J, Gudbjörnsdottir S, Eliasson B, Zethelius B, Eeg-Olofsson K, Nilsson P (2012) Blood pressure and risk of cardiovascular diseases in type 2 diabetes: further findings from the Swedish National Diabetes Register (NDR-BP II). J Hypertens 30:2020–2030CrossRefPubMed
21.
go back to reference Eliasson B, Gudbjörnsdottir S, Zethelius B, Eeg-Olofsson K (2014) Cederholm J; on behalf of the NDR. LDL-cholesterol versus non-HDL-to-HDL-cholesterol ratio and risk for coronary heart disease in type 2 diabetes. Eur J Prev Cardiol 21:1420–1428CrossRefPubMed Eliasson B, Gudbjörnsdottir S, Zethelius B, Eeg-Olofsson K (2014) Cederholm J; on behalf of the NDR. LDL-cholesterol versus non-HDL-to-HDL-cholesterol ratio and risk for coronary heart disease in type 2 diabetes. Eur J Prev Cardiol 21:1420–1428CrossRefPubMed
22.
go back to reference Hoelzel W, Weykamp C, Jeppsson JO et al (2004) IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study. Clin Chem 50:166–174CrossRefPubMed Hoelzel W, Weykamp C, Jeppsson JO et al (2004) IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study. Clin Chem 50:166–174CrossRefPubMed
23.
go back to reference Merlo J, Lindblad U, Pessah-Rasmussen H et al (2000) Comparison of different procedures to identify probable cases of myocardial infarction and stroke in two Swedish prospective cohort studies using local and national routine registers. Eur J Epidemiol 16:235–243CrossRefPubMed Merlo J, Lindblad U, Pessah-Rasmussen H et al (2000) Comparison of different procedures to identify probable cases of myocardial infarction and stroke in two Swedish prospective cohort studies using local and national routine registers. Eur J Epidemiol 16:235–243CrossRefPubMed
24.
go back to reference Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A (1994) Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 90:583–612CrossRefPubMed Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A (1994) Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 90:583–612CrossRefPubMed
25.
go back to reference Rockhill B, Newman B, Weinberg C (1998) Use and misuse of population attributable fractions. Am J Public Health 38:15–19CrossRef Rockhill B, Newman B, Weinberg C (1998) Use and misuse of population attributable fractions. Am J Public Health 38:15–19CrossRef
26.
go back to reference Watanabe H, Tanabe N, Watanabe T et al (2008) Metabolic syndrome and risk of development of atrial fibrillation: the Niigata preventive medicine study. Circulation 117:1255–1260PubMedCentralCrossRefPubMed Watanabe H, Tanabe N, Watanabe T et al (2008) Metabolic syndrome and risk of development of atrial fibrillation: the Niigata preventive medicine study. Circulation 117:1255–1260PubMedCentralCrossRefPubMed
27.
28.
go back to reference Lind M, Olsson M, Rosengren A, Svensson AM, Bounias I, Gudbjörnsdottir S (2012) The relationship between glycaemic control and heart failure in 83,021 patients with type 2 diabetes. Diabetologia 55:2946–2953CrossRefPubMed Lind M, Olsson M, Rosengren A, Svensson AM, Bounias I, Gudbjörnsdottir S (2012) The relationship between glycaemic control and heart failure in 83,021 patients with type 2 diabetes. Diabetologia 55:2946–2953CrossRefPubMed
29.
go back to reference Nilsson PM, Cederholm J, Zethelius B, Eliasson B, Eeg-Olofsson K, Gudbjörnsdottir S (2011) Trends in blood pressure control in patients with type 2 diabetes – data from the Swedish National Diabetes Register (NDR). Blood Press 20:348–354CrossRefPubMed Nilsson PM, Cederholm J, Zethelius B, Eliasson B, Eeg-Olofsson K, Gudbjörnsdottir S (2011) Trends in blood pressure control in patients with type 2 diabetes – data from the Swedish National Diabetes Register (NDR). Blood Press 20:348–354CrossRefPubMed
30.
go back to reference Cederholm J, Eliasson B, Zethelius B, Eeg-Olofsson K, Gudbjörnsdottir S (2013) Risk factors for cardiovascular disease. Results from the Swedish National Diabetes Register compared with international studies. A report from the Swedish National Diabetes Registry (NDR). (Abstract in English [Article in Swedish]). Lakartidningen 17–18:882–885 Cederholm J, Eliasson B, Zethelius B, Eeg-Olofsson K, Gudbjörnsdottir S (2013) Risk factors for cardiovascular disease. Results from the Swedish National Diabetes Register compared with international studies. A report from the Swedish National Diabetes Registry (NDR). (Abstract in English [Article in Swedish]). Lakartidningen 17–18:882–885
31.
go back to reference Frost L, Juul Hune L, Vestergaard P (2005) Overweight and obesity as risk factors for atrial fibrillation or flutter: the Danish diet, cancer, and health study. Am J Med 118:489–495CrossRefPubMed Frost L, Juul Hune L, Vestergaard P (2005) Overweight and obesity as risk factors for atrial fibrillation or flutter: the Danish diet, cancer, and health study. Am J Med 118:489–495CrossRefPubMed
32.
go back to reference Abed HS, Wittert GA, Leong DP et al (2013) Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial. JAMA 310:2050–2060CrossRefPubMed Abed HS, Wittert GA, Leong DP et al (2013) Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial. JAMA 310:2050–2060CrossRefPubMed
33.
go back to reference Conen D, Glynn RJ, Sandhu RK, Tedrow UB, Albert CM (2013) Risk factors for incident atrial fibrillation with and without left atrial enlargement in women. Int J Cardiol 168:1894–1899PubMedCentralCrossRefPubMed Conen D, Glynn RJ, Sandhu RK, Tedrow UB, Albert CM (2013) Risk factors for incident atrial fibrillation with and without left atrial enlargement in women. Int J Cardiol 168:1894–1899PubMedCentralCrossRefPubMed
34.
go back to reference Wang TJ, D’Agostino R Sr, Vasan RS et al (2004) Obesity and the risk of new-onset atrial fibrillation. JAMA 292:2471–2477CrossRefPubMed Wang TJ, D’Agostino R Sr, Vasan RS et al (2004) Obesity and the risk of new-onset atrial fibrillation. JAMA 292:2471–2477CrossRefPubMed
35.
go back to reference Miyasaka Y, Barnes ME, Gersh BJ et al (2007) Coronary ischemic events after first atrial fibrillation: risk and survival. Am J Med 120:357–363CrossRefPubMed Miyasaka Y, Barnes ME, Gersh BJ et al (2007) Coronary ischemic events after first atrial fibrillation: risk and survival. Am J Med 120:357–363CrossRefPubMed
36.
go back to reference Wang TJ, Larson MG, Levy D et al (2003) Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation 107:2920–2925CrossRefPubMed Wang TJ, Larson MG, Levy D et al (2003) Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation 107:2920–2925CrossRefPubMed
Metadata
Title
Risk factors for atrial fibrillation in type 2 diabetes: report from the Swedish National Diabetes Register (NDR)
Authors
Björn Zethelius
Soffia Gudbjörnsdottir
Björn Eliasson
Katarina Eeg-Olofsson
Ann-Marie Svensson
Jan Cederholm
Publication date
01-10-2015
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 10/2015
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-015-3666-9

Other articles of this Issue 10/2015

Diabetologia 10/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine